PI-103 hydrochloride is a potent compound that inhibits PI3 kinase activity. It targets ATM, ATR, DNA-PK, hsVPS34, mTORC1, mTORC2, p110α, p110β, p110δ, p110γ, and PI3KC2α.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.